Morgan Stanley's Top Biotech Pick is Biogen

By: via Benzinga
On Thursday, Morgan Stanley initiated coverage on a number of biotech companies, rating both Amgen (NASDAQ: AMGN) and Biogen (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.